{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:02:18Z","timestamp":1790805738766,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.eprac.2026.05.003","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:03:14Z","timestamp":1778587394000},"page":"1475-1482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Once-Weekly Insulin Icodec: Safety Profile in Type 2 and Type 1 Diabetes Based on a Pooled Analysis of ONWARDS 1-6"],"prefix":"10.1016","volume":"32","author":[{"given":"Harpreet S.","family":"Bajaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie Bech","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boryana","family":"Hristova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Hulkund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kellerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri","family":"Vinther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildiko","family":"Lingvay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.eprac.2026.05.003_bib1","first-page":"S181","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"issue":"9733","key":"10.1016\/j.eprac.2026.05.003_bib2","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.eprac.2026.05.003_bib3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00024677-200302020-00003","article-title":"Diabetic ketoacidosis: risk factors and management strategies","volume":"2","author":"Umpierrez","year":"2003","journal-title":"Treat Endocrinol"},{"issue":"9735","key":"10.1016\/j.eprac.2026.05.003_bib4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.eprac.2026.05.003_bib5","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2337\/dc10-0666","article-title":"Diabetes and cancer: a consensus report","volume":"33","author":"Giovannucci","year":"2010","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.eprac.2026.05.003_bib6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.clindermatol.2010.11.009","article-title":"Insulin allergy","volume":"29","author":"Ghazavi","year":"2011","journal-title":"Clin Dermatol"},{"issue":"5","key":"10.1016\/j.eprac.2026.05.003_bib7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/pds.5212","article-title":"Outpatient insulin-related adverse events due to mix-up errors: findings from two national surveillance systems, United States, 2012-2017","volume":"30","author":"Geller","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"10.1016\/j.eprac.2026.05.003_bib8","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.2337\/db08-1084","article-title":"The barrier of hypoglycemia in diabetes","volume":"57","author":"Cryer","year":"2008","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.eprac.2026.05.003_bib9","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1463-1326.2012.01636.x","article-title":"Factors associated with injection omission\/non-adherence in the Global Attitudes of Patients and Physicians in Insulin Therapy study","volume":"14","author":"Peyrot","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.eprac.2026.05.003_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111885","volume":"217","author":"Polonsky","year":"2024","journal-title":"Diabetes Res Clin Prac"},{"issue":"2","key":"10.1016\/j.eprac.2026.05.003_bib11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/dom.14871","article-title":"Rationale and design of the phase 3a development programme (ONWARDS 1-6 trials) investigating once-weekly insulin icodec in diabetes","volume":"25","author":"Philis-Tsimikas","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.eprac.2026.05.003_bib12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJMoa2303208","article-title":"Weekly icodec versus daily glargine U100 in type 2 diabetes without previous insulin","volume":"389","author":"Rosenstock","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.eprac.2026.05.003_bib13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S2213-8587(23)00093-1","article-title":"Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial","volume":"11","author":"Philis-Tsimikas","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2026.05.003_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jama.2023.11313","article-title":"Once-weekly insulin icodec vs once-daily insulin degludec in adults with insulin-naive type 2 diabetes: the ONWARDS 3 randomized clinical trial","volume":"330","author":"Lingvay","year":"2023","journal-title":"JAMA"},{"issue":"10392","key":"10.1016\/j.eprac.2026.05.003_bib15","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(23)00520-2","article-title":"Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial","volume":"401","author":"Mathieu","year":"2023","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.eprac.2026.05.003_bib16","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.7326\/M23-1288","article-title":"Once-weekly insulin icodec with dosing guide app versus once-daily basal insulin analogues in insulin-naive type 2 diabetes (ONWARDS 5): a randomized trial","volume":"176","author":"Bajaj","year":"2023","journal-title":"Ann Intern Med"},{"issue":"10413","key":"10.1016\/j.eprac.2026.05.003_bib17","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/S0140-6736(23)02179-7","article-title":"Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial","volume":"402","author":"Russell-Jones","year":"2023","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.eprac.2026.05.003_bib18","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1111\/dom.15726","article-title":"Once-weekly insulin icodec compared with daily basal insulin analogues in type 2 diabetes: participant-level meta-analysis of the ONWARDS 1-5 trials","volume":"26","author":"Bajaj","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"10.1016\/j.eprac.2026.05.003_bib22","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s40265-025-02201-0","article-title":"Clinical use of once-weekly insulin icodec: translating clinical trial data into practical guidance for diabetes management","volume":"85","author":"Philis-Tsimikas","year":"2025","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.eprac.2026.05.003_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.eprac.2024.11.009","article-title":"Pharmacokinetic\/pharmacodynamic modeling of efficacy and hypoglycemia rate when switching from once-daily basal insulin to once-weekly insulin icodec without or with a one-time additional dose in insulin-experienced individuals with type 2 diabetes","volume":"31","author":"Lingvay","year":"2025","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2026.05.003_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabet.2017.10.014","article-title":"Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes","volume":"44","author":"Feldman-Billard","year":"2018","journal-title":"Diabetes Metab"},{"issue":"1","key":"10.1016\/j.eprac.2026.05.003_bib26","doi-asserted-by":"crossref","first-page":"P66","DOI":"10.1016\/j.ophtha.2019.09.025","article-title":"Diabetic retinopathy preferred practice pattern\u00ae","volume":"127","author":"Flaxel","year":"2020","journal-title":"Ophthalmology"},{"issue":"9090","key":"10.1016\/j.eprac.2026.05.003_bib27","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(97)06234-X","article-title":"Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS\/MEMO collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit","volume":"350","author":"Morris","year":"1997","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.eprac.2026.05.003_bib28","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1111\/dom.15266","article-title":"Pharmacokinetic and pharmacodynamic properties of once-weekly insulin icodec in individuals with type 2 diabetes","volume":"25","author":"Pieber","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.eprac.2026.05.003_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002301","article-title":"Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing","volume":"9","author":"Nishimura","year":"2021","journal-title":"BMJ Open Diabetes Res Care"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26009705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26009705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:49:15Z","timestamp":1790804955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26009705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1530891X26009705"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.05.003","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Once-Weekly Insulin Icodec: Safety Profile in Type 2 and Type 1 Diabetes Based on a Pooled Analysis of ONWARDS 1-6","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}